| Twinlab Corporation Issues Statement in Response to FDA Warning Letter Concerning Androstenedione |
|
Home
|
HAUPPAUGE, N.Y., Mar 12, 2004 -- Twinlab Corporation, a wholly-owned subsidiary of IdeaSphere, Inc. today issued the following statement in response to the US Food and Drug Administration's warning letter to Twinlab Corporation concerning products containing androstenedione, or "andro": Twinlab Corporation respectfully disagrees with the conclusions We believe that Twinlab androstenedione products are safe and Twinlab is currently manufacturing and will commence selling a new IdeaSphere Inc. and Twinlab Corporation share the FDA's commitment About Twinlab Twinlab, based in Hauppauge, NY, is the leading manufacturer and marketer of high quality, science-based, nutritional supplements, including a robust line of vitamins, minerals, specialty supplements, herbs, teas and sports nutrition products. About IdeaSphere, Inc. IdeaSphere, Inc., with offices in New York, NY, Hauppauge, NY, Grand Rapids, Michigan, and American Fork, Utah, is the champion of the Wellness Revolution. A purpose-built, vertically integrated health and wellness company, it provides total wellness solutions through its holdings, which include leaders in wellness products, content and services. IdeaSphere's family of companies includes Twinlab Corporation; Rebus LLC, and iVillage Solutions. |
| Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software | |
This article has been moved here